Ramesh Juneja has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
MANKIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Ramesh Juneja, a promoter of Mankind Pharma, has submitted a disclosure to NSE under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. This regulation requires promoters and persons acting in concert holding 5% or more shares to disclose details of any encumbrances (such as pledges) on their shareholdings. The specific details of the disclosure — such as whether shares were pledged, released, or invoked — are not provided in this filing headline.
This is a routine regulatory compliance filing by the promoter. Without the actual disclosure details, shareholders should monitor for any accompanying filing that reveals the nature and extent of encumbrance changes on promoter holdings, which could affect stock sentiment.